Human Blood Cell Disorders Tissue Bank

Conditions

• Human Blood Cell Disorders
• Lymphoid, Myeloid and Erythroid Proliferative Disease

Eligibility Criteria

Sex

ALL

Age

18 Years - 100 Years

Healthy Volunteers

Accepted

Study Details

The Human Blood Cell Disorder Tissue Bank will provide a convenient, comprehensive source of tissue containing populations of human blood cells from patients with various types of lymphoid, myeloid, and erythroid proliferative diseases as well as other associated conditions. The tissue bank will continue to be an invaluable asset for understanding of the biology of multiple blood cell disorders involving several cell types as well as the physiology of normal cellular counterparts affected in these disorders. Internal and external investigators will be able to utilize this tissue to test hypotheses relating to the immunologic, virologic, genetic, and molecular properties of these abnormal cells as well as normal cells from normal unaffected family members or normal aged matched subjects to provide better comparisons.

Key Dates

Start date

Apr 30, 2009

Status verified

Mar 2024

Primary completion

Jan 31, 2030

Completion

Jan 31, 2035

Study Design

Enrollment

10,000 participants (estimated)

Arms

• Arm: Human Blood Cell Disorders
  Human Blood Cell Disorders Tissue Bank

Primary Outcome Measure

Accumulate tissue from patients with various blood disorders, including but not restricted to lymphoproliferative, myeloproliferative, and erythroproliferative conditions. [ Time Frame: Indefinite ]

Central Contacts

• Yasmine Kieso, MSCR
  [email protected]

Locations (1)

Find similar trials in Manhasset, NY